Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer
- 1 February 2022
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 234, 108123
Abstract
No abstract availableKeywords
Funding Information
- Shandong Province Natural Science Foundation
- National Natural Science Foundation of China
- Jiangsu Province Natural Science Foundation
This publication has 195 references indexed in Scilit:
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive reviewEMBO Molecular Medicine, 2012
- Cancer biomarkersMolecular Oncology, 2012
- Molecular Mechanisms of Long Noncoding RNAsMolecular Cell, 2011
- MacroRNA underdogs in a microRNA world: Evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNABiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasisNature, 2010
- A blood‐based biomarker panel for stratifying current risk for colorectal cancerInternational Journal of Cancer, 2009
- Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer CellsCell, 2009
- Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem CellsCell Stem Cell, 2008
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007
- MicroRNA expression profiles classify human cancersNature, 2005